We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
Cap. Flow
+$8.89B
Cap. Flow %
8.09%
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.35B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.85B
3
LLY icon
Eli Lilly
LLY
+$999M
4
KO icon
Coca-Cola
KO
+$685M
5
AVGO icon
Broadcom
AVGO
+$616M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.38B
2
AAPL icon
Apple
AAPL
+$1.12B
3
NFLX icon
Netflix
NFLX
+$678M
4
BSX icon
Boston Scientific
BSX
+$671M
5
COR icon
Cencora
COR
+$627M

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Consumer Discretionary 12.77%
3 Healthcare 10.45%
4 Financials 7.74%
5 Communication Services 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
3151
Heron Therapeutics
HRTX
$86.3M
-1,308,861
Closed -$1.65M
HSIC icon
3152
Henry Schein
HSIC
$9.74B
-181,521
Closed -$12M
HUBB icon
3153
Hubbell
HUBB
$25.7B
-1,841
Closed -$792K
HUBG icon
3154
HUB Group
HUBG
$3.01B
-9,537
Closed -$328K
HVT icon
3155
Haverty Furniture Companies
HVT
$401M
-42,231
Closed -$926K
HYLN icon
3156
Hyliion Holdings
HYLN
$663M
-183,326
Closed -$361K
IBIT icon
3157
PUT
iShares Bitcoin Trust
IBIT
$47.2B
-600,000
Closed -$39M
IBRX icon
3158
ImmunityBio
IBRX
$7.44B
-254,814
Closed -$627K
IDT icon
3159
IDT Corp
IDT
$1.6B
-5,196
Closed -$272K
IHI icon
3160
iShares US Medical Devices ETF
IHI
$3.02B
-25,552
Closed -$1.54M
IJR icon
3161
iShares Core S&P Small-Cap ETF
IJR
$109B
-9,121
Closed -$1.08M
IMVT icon
3162
Immunovant
IMVT
$8.09B
-419,680
Closed -$6.77M
INBK icon
3163
First Internet Bancorp
INBK
$231M
-27,083
Closed -$607K
INFA
3164
DELISTED
Informatica
INFA
-11,300
Closed -$281K
INSE icon
3165
Inspired Entertainment
INSE
$177M
-50,297
Closed -$472K
INTA icon
3166
Intapp
INTA
$2.12B
-276,063
Closed -$11.3M
IPG
3167
DELISTED
Interpublic Group of Companies
IPG
-432,628
Closed -$12.1M
IPSC icon
3168
Century Therapeutics
IPSC
$381M
-54,161
Closed -$27.1K
IR icon
3169
Ingersoll Rand
IR
$33B
-260,537
Closed -$21.5M
IRT icon
3170
Independence Realty Trust
IRT
$3.92B
-238,737
Closed -$3.91M
IRS
3171
IRSA Inversiones y Representaciones
IRS
$1.26B
-122,275
Closed -$1.45M
ISRG icon
3172
PUT
Intuitive Surgical
ISRG
$121B
-210,200
Closed -$94M
ITA icon
3173
iShares US Aerospace & Defense ETF
ITA
$14.2B
-5,100
Closed -$1.07M
ITT icon
3174
ITT
ITT
$17.5B
-1,288
Closed -$230K
IX icon
3175
ORIX
IX
$44B
-58,493
Closed -$1.53M

Similar funds

Marshall Wace's Q4 2025 Portfolio in Review

As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.

  • Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
  • Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
  • Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
  • Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
  • Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.